Serum Anti-cholesterol Antibodies in Chronic Hepatitis-C Patients During IFN-α-2b Treatment
- 31 December 2003
- journal article
- Published by Elsevier in Immunobiology
- Vol. 207 (3) , 161-168
- https://doi.org/10.1078/0171-2985-00229
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- High Level of Anticholesterol Antibodies (ACHA) in HIV Patients. Normalization of Serum ACHA Concentration after Introduction of HAARTImmunobiology, 2001
- Anti-cholesterol antibodies (ACHA) in patients with different atherosclerotic vascular diseases and healthy individuals. Characterization of human ACHAAtherosclerosis, 2001
- Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon α-2bImmunology Letters, 2000
- Extrahepatic Manifestations Associated with Hepatitis C Virus Infection: A Prospective Multicenter Study of 321 PatientsMedicine, 2000
- Hepatitis C—virology and future antiviral targetsThe American Journal of Medicine, 1999
- Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infectionThrombosis Research, 1996
- Changes in Blood Lipid Composition and Response to Interferon Treatment in Chronic Hepatitis CJournal of Interferon & Cytokine Research, 1995
- Density heterogeneities of hepatitis C virus in human sera due to the binding of ?-lipoproteins and immunoglobulinsMedical Microbiology and Immunology, 1993
- Fluid phase generation of terminal complement complex as a novel index of bioincompatibilityKidney International, 1990
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981